Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Same-day discharge safe, feasible for patients undergoing transarterial chemoembolization procedures
New research published in Clinical Imaging shows that patients undergoing TACE can forego dayslong hospital stays without no negative consequences.
Mangione enters plea of 'not guilty' as federal trial moves forward
Luigi Mangione has officially entered a plea in the indictment against him for the murder of UnitedHealthcare CEO Brian Thompson. The federal case is now expected to move forward before the overlapping state murder trial, as the Department of Justice is seeking the death penalty.
FDA announces new recall of Abbott heart pump accessories over significant safety risks
The mobile power units of certain HeartMate 3 and HeartMate II LVADs have been experiencing “sudden, unexpected performance issues” such as turning on, off or even restarting with no warning. These issues can potentially be fatal, according to an alert shared by the FDA.
‘Innovative’ pay model eliminates cost uncertainty for breast and lung cancer screening patients
Experts have proposed “episode-based cost sharing” to address financial toxicity for healthcare consumers, according to new research published in JACR.

How the Mark Cuban prescription drug playbook could save taxpayers billions

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

US Radiology Specialists hires executive from its private equity backer to fill out C-suite

Paul Taheri, MD, MBA, will serve as chief clinical officer following his time as clinical partner at Welsh, Carson, Anderson & Stowe.

Radiology societies issue ‘call to action’ against looming threat to physician offices’ financial viability

ACR, SIR, ASTRO and others are concerned about about forthcoming cuts in the Medicare Physician Fee Schedule that will impact specialties with high equipment costs.

ChatGPT effectively simplifies radiology reports, presents 'real opportunity' to better inform patients

Radiology reports are typically written in language well above the average American adult’s eighth grade reading level, making them a source of confusion for patients.

Interventional radiology among 4 specialties with the greatest growth in claims volume since 2018

The specialty saw an 83% uptick in billing between 2018 and 2022, publicly traded data and analytics firm Definitive Healthcare reported.

Do clinicians want radiologists' management advice? Interviews shed some light on 'unwanted' recommendations

Clinicians only want the information they need to make treatment decisions, rather than advice on what actions they should take, the survey found.

healthcare value value-based care money dollar

Bitterroot Bio, a new biotech company launched by physicians and industry veterans, raises $145M

The new company formed in 2021, but waited until now to publicly launch. Its founders included two Stanford University physicians.

Management

HHS sued over RFK’s $11B cuts to infectious disease control

Same-day discharge safe, feasible for patients undergoing transarterial chemoembolization procedures

Mangione enters plea of 'not guilty' as federal trial moves forward

FDA announces new recall of Abbott heart pump accessories over significant safety risks

‘Innovative’ pay model eliminates cost uncertainty for breast and lung cancer screening patients